Table 1.
Patient or population: children needing dental care Setting: hospital Intervention: sedative Comparison: placebo | ||||||
---|---|---|---|---|---|---|
Outcomes | Anticipated absolute effects (95% CI) | Relative effect (95% CI) | Number of participants (studies) | Certainty of the evidence (GRADE) | Comments | |
Risk with Placebo | Risk with Sedative | |||||
Houpt/other behavioural score—Midazolam (oral) SD units: investigators measure behaviour using different scales—Higher values mean better behaviour |
The Houpt/other behavioural score in the midazolam (oral) group was on average 1.96 SDs higher (1.59 higher to 2.33 higher) than the placebo group | 202 (6 RCTs) |
⊕ ⊕ ⊕ ⊝ MODERATE1 |
As a rule of thumb 0.2 SD represents a small difference, 0.5 a moderate difference, and 0.8 a large difference Adverse events: vomiting/hiccupping reported in one study. Amnesia reported in one study Oral midazolam probably improves behaviour |
||
Houpt/other behavioural score—Midazolam (intravenous) SD units: investigators measure behaviour using different scales—Higher values mean better behaviour |
The Houpt/other behavioural score in the midazolam (intravenous) group was on average 1.21 SDs higher (0.24 higher to 2.18 higher) than the placebo group | 20 (1 RCT) |
⊕ ⊝ ⊝ ⊝ VERY LOW1, 2 |
As a rule of thumb 0.2 SD represents a small difference, 0.5 a moderate difference, and 0.8 a large difference No adverse events reported Uncertain whether intravenous midazolam improves behaviour |
||
Houpt/other behavioural score—Nitrous oxide SD units: investigators measure behaviour using different scales—Higher values mean better behaviour |
The Houpt/other behavioural score in the nitrous oxide group was on average 0.69 SDs higher (0.13 higher to 1.26 higher) than the placebo group | 52 (1 RCT) |
⊕ ⊝ ⊝ ⊝ VERY LOW1, 3 |
As a rule of thumb 0.2 SD represents a small difference, 0.5 a moderate difference, and 0.8 a large difference No adverse events reported Uncertain whether nitrous oxide improves behaviour |
||
Houpt/other behavioural score—Diazepam (oral) SD units: investigators measure behaviour using different scales—Higher values mean better behaviour |
The Houpt/other behavioural score in the diazepam (oral) group was on average 0.62 SDs higher (0.28 lower to 1.53 higher) than the placebo group | 20 (1 RCT) |
⊕ ⊝ ⊝ ⊝ VERY LOW1, 2 |
As a rule of thumb 0.2 SD represents a small difference, 0.5 a moderate difference, and 0.8 a large difference No adverse events reported Uncertain whether oral diazepam improves behaviour |
||
Good or better behaviour—Chloral hydrate | Study population | RR 1.33 (0.80–2.22) | 60 (1 RCT) |
⊕ ⊝ ⊝ ⊝ VERY LOW3, 4 |
Adverse events: associated with airway problems Uncertain whether chloral hydrate improves behaviour |
|
533 per 1000 | 709 per 1000 (427–1000) | |||||
Good or better behaviour—Meperidine | Study population | RR 5.33 (1.45–19.64) | 60 (1 RCT) |
⊕ ⊕ ⊝ ⊝ LOW5 |
Adverse events: nausea, vomiting and unmanageable behaviour were associated with meperidine use Meperidine may improve behaviour |
|
133 per 1000 | 711 per 1000 (193–1000) |
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
CI confidence interval; RCT randomised controlled trial; RR risk ratio; SD standard deviation; SMD standardized mean difference
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI)
1Downgraded for risk of bias (lack of blinding and randomisation processes unclear)
2Downgraded for imprecision (large confidence interval and small numbers)
3Downgraded for imprecision (large confidence interval)
4Downgraded for risk of bias (randomisation unclear and incomplete outcome assessment)
5Downgraded for risk of bias (randomisation unclear) and imprecision